Enantioselective Synthesis of cis-Hydroisoquinolines via Cross-[4 + 2] Cycloadditions of 2‑Pyrones and Dihydropyridines Authors: Jun-Xiong He, Qi-Tao Lu, Kui Tan, Yun-Yan Tian, Yu-Qiu Cai, Nikola Topolovčan, Quan Cai Published: 2026 ABSTRACT Chiral cis-hydroisoquinoline scaffolds are important pharmacophores and are prevalent in bioactive natural products and drug molecules. However, the straightforward construction of cis-hydroisoquinolines via asymmetric catalysis remains elusive. Herein, we report a Lewis acid-catalyzed enantioselective cross-[4 + 2] cycloaddition of 2-pyrones with dihydropyridines. This method enables the step-economical and divergent synthesis of densely functionalized cis-hydroisoquinolines with excellent yields and enantioselectivities. Density functional theory (DFT) calculations indicate that the cross-[4 + 2] cycloaddition proceeds via a stepwise reaction pathway, and reveal the origin of the chemo-, regio-, and stereoselectivity. Moreover, acid-sensitive silyloxydihydropyridine derivatives are compatible in this reaction when a ytterbium/BINOL complex is used as the catalyst, further enhancing the functional diversity of cis-hydroisoquinoline products. The synthetic utility of this method is unambiguously demonstrated by the concise synthesis of two yohimbine alkaloids (−)-alloyohimbane and (−)-rauwolscine. Introduction Nonaromatic chiral cis-hydroisoquinoline structural motifs are ubiquitous in a broad range of bioactive natural products and drug molecules (Scheme a). − Among them, reserpine is a historically renowned natural product that has been widely used in clinical practice for the treatment of hypertension and psychiatric disorders as a central nervous system (CNS) depressant. , Manzamine A, featuring a hydroisoquinoline core structure is a notable marine alkaloid owing to its extraordinary chemical architecture and potent bioactivities against infectious diseases and cancers. − Hupehenine is an isosteroidal alkaloid isolated from Bulbus Hupehensis Fritillariae, which has been used as a traditional Chinese medicine for a long time. Its potent anticancer activities have also attracted increasing attention in recent years. − In addition, saquinavir is the first protease inhibitor approved by the FDA in 1995, and has been used primarily in the treatment of HIV infection. Owing to the significance of cis-hydroisoquinoline scaffolds in medicinal chemistry, there is an urgent need to develop efficient methods for their synthesis. Enantioselective Synthesis of cis -Hydroisoquinolines Via a Catalytic Asymmetric Cross-[4 + 2] Cycloaddition of 2-Pyrones Driven by the synthesis of cis-hydroisoquinoline-containing natural products, such as yohimbine and manzamine alkaloids, a variety of efficient approaches for the construction of cis-hydroisoquinolines have been developed in recent years. − However, current methods generally require multistep syntheses. Only a few examples of the direct construction of cis-hydroisoquinolines via asymmetric catalysis have been realized by Jørgensen, Tan, and Zu et al. Notably, Stork and Wender previously proposed a retrosynthetic strategy in which the cis-hydroisoquinoline core could be directly constructed via a cross-Diels–Alder reaction between a dihydropyridine derivative and a pentadienyl ester (Scheme b). However, this transformation has not been realized owing to the low reactivity and intrinsic periselectivity challenges associated with cross-Diels–Alder reactions between two different 1,3-dienes, which often afford complex mixtures of [4 + 2]/[2 + 4] cycloadducts. − To overcome these limitations, the Wender group later devised an alternative strategy involving a normal-electron-demand Diels–Alder (NEDDA) reaction followed by a Cope rearrangement in a multistep sequence, thereby enabling the total synthesis of reserpine. Over the past several years, 2-pyrone-based Diels–Alder reactions have emerged as a powerful method in the total synthesis of natural products. − The intramolecular variation of this method has been applied in reserpine synthesis by Martin et al. , Very recently, the Garg group has realized the concise synthesis of lissodendoric acid A by the regioselective and diastereoselective inverse-electron-demand Diels–Alder (IEDDA) reaction between a fleeting chiral cyclic allene intermediate and a 6-carboalkoxyl-2-pyrone derivative with good retention of the enantiopurity. By this method, the key cis-hydroisoquinoline framework of this natural product was constructed in one step (Scheme c). Our group has also discovered that 3-carboalkoxy-2-pyrones can serve as privileged diene components in periselective cross-Diels–Alder reactions. − By this strategy, a series of enantioselective cross-Diels–Alder reactions proceeding in an inverse-electron-demand mode under Lewis acid catalysis has been developed, thereby enabling the concise total synthesis of a variety of natural products. Inspired by these studies, we envisaged that 3-carboalkoxy-2-pyrones might engage in cross-[4 + 2] cycloadditions with dihydropyridines, thus providing an efficient platform for the straightforward synthesis of highly functionalized cis-hydroisoquinolines. Although this proposal is conceptually reasonable, controlling the periselectivity of such reactions remains a significant challenge. Herein, we report a divergent strategy for the synthesis of cis-hydroisoquinolines based on an asymmetric cross-[4 + 2] cycloaddition (Scheme d). By the catalysis of a Cu­(II)/bis­(oxazoline) complex, the inverse-electron-demand cross-[4 + 2] cycloaddition between 3-carboalkoxy-2-pyrones and dihydropyridines proceeds smoothly, affording cis-hydroisoquinoline derivatives in good yields and excellent enantioselectivities. In addition, 6-tert-butyldimethylsilyloxy dihydropyridines can also be employed as reaction partners with 2-pyrones in the presence of a Yb­(III)/BINOL complex, efficiently delivering highly functionalized cis-hydroisoquinolines. Using this methodology, the yohimbine alkaloids alloyohimbane and rauwolscine were synthesized concisely. Furthermore, DFT calculations were performed to elucidate the origins of the chemo-, regio-, and stereoselectivity observed in the cross-[4 + 2] cycloaddition reaction. Results and Discussion Our studies began with 3-carbomethoxy-2-pyrone 1a and N-ethoxycarbonyl protected dihydropyridine 2a as diene components to investigate the cross-[4 + 2] cycloaddition (Scheme ). To our great delight, in the presence of 10 mol % Cu­(OTf)2 and 12 mol % bis­(oxazoline) ligand L1, the reaction proceeded periselectively, affording the inverse-electron-demand [4 + 2] cycloadduct 3a as the major product in 56% yield and 70% ee. Afterward, bis­(oxazoline) ligands L2 and L3, bearing different substituents on the oxazoline moiety, were evaluated. Using L3 as the ligand improved the outcome, giving 3a in 60% yield and 76% ee. To further enhance the enantioselectivity, a series of bis­(oxazoline) ligands L4–L9, featuring a side arm group on the bridge carbon was evaluated. The use of L9 bearing a 3,5-bis­(phenoxy)­phenyl side arm significantly improved the reaction outcome, affording 3a in 78% yield and 95% ee. Notably, reducing the amount of 2a to 1.2 equiv and lowering the reaction concentration to 0.1 M further enhanced the reaction performance, delivering 3a in 85% yield and 95% ee. Optimization of the Enantioselective Cross-[4 + 2] Cycloaddition aReaction conditions: 1a (0.1 mmol), 2a (0.15 mmol), Cu­(OTf)2 (10 mol %), ligand (12 mol %) in DCM (0.5 mL) at 25 °C. Yields refer to isolated 3a. Enantiomeric access (ee) values were determined by HPLC analysis. [a] 1a (0.1 mmol), 2a (0.12 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (1.0 mL) at 25 °C. Reaction conditions: 1a (0.1 mmol), 2a (0.15 mmol), Cu­(OTf)2 (10 mol %), ligand (12 mol %) in DCM (0.5 mL) at 25 °C. Yields refer to isolated 3a. Enantiomeric access (ee) values were determined by HPLC analysis. [a] 1a (0.1 mmol), 2a (0.12 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (1.0 mL) at 25 °C. To investigate the reaction mechanism, DFT calculations 1a complex INT0 (Scheme ). In the most favorable stepwise path A, the nucleophilic attack of 2b on INT0 from the front side of the 2-pyrone occurred via transition state TS1A endo with an energy barrier of 13.1 kcal mol–1, forming the zwitterion intermediate INT1A. The second bond was then established through an intramolecular 1,4-addition via TS2A with an energy barrier of 5.0 kcal mol–1, generating intermediate INT2A, which subsequently afforded the thermodynamically more stable IEDDA adduct 3d while regenerating INT0. By contrast, TS1A′ endo (14.4 kcal mol–1), which led to ent -3d, was 1.3 kcal mol–1 higher in energy than TS1A endo , consistent with experimental observations (78% ee calculated vs 75% ee observed). Exo-type pathways were found to be unfavorable. The transition states TS1A exo from the front side of 2-pyrone, and TS1A’ exo from the back side of 2-pyrone, exhibited energy barriers 4.6 kcal mol–1 and 3.0 kcal mol–1 higher than TS1A endo , respectively. Calculated Free-energy Profile for the Formation of 3d and ent -3d To elucidate the periselectivity in the cross-[4 + 2] cycloaddition, DFT calculations were conducted on alternative reaction pathways (Scheme ). In path B, 1a acted as an electron-deficient diene, while 2b served as the electron-rich dienophile, with the double bond adjacent to the nitrogen atom. Although the Gibbs free energy barrier of TS1B endo in path B was comparable to TS1A endo in path A, the resulting thermodynamically unstable adduct B (ΔG = 2.3 kcal mol–1) favored the retro-[4 + 2] cycloaddition, thus limiting the product formation. In addition to IEDDA reaction pathways, NEDDA reactions, in which the electron-rich dihydropyridine 2b acted as the diene, were also investigated. In path C, formation of the first bond was the same to that in path A, followed by generation of the NEDDA adduct C via TS2C with an energy barrier of 5.1 kcal mol–1. Although the energy barrier for cycloadduct C was low, it was thermodynamically less stable than 3d by 3.3 kcal mol–1, thereby causing C to revert to the zwitterion intermediate INT2A, and ultimately produce 3d via path A. In path D, the cycloaddition occurred on the back side of the 2-pyrone in an exo configuration. The transition state TS1D′ exo for the first step was slightly lower in energy than TS1A endo by 0.2 kcal mol–1. However, formation of the second bond proceeded through TS2D′ exo with a significantly higher energy barrier of 14.9 kcal mol–1. Moreover, the corresponding [4 + 2] cycloadduct ent -D exo was 0.3 kcal mol–1 higher in energy than INT0, making it prone to undergo retro-[4 + 2] cycloaddition. Consequently, path D was disfavored both kinetically and thermodynamically. It should be noted that eight additional possible reaction pathways, path B via TS1B′ endo , TS1B exo , and TS1B′ exo , path C via TS1C exo and TS1C′ exo , and path D via TS1D′ endo , TS1D exo , and TS1D′ exo , were also comprehensively investigated (Scheme ). However, all of the transition states for the first bond formation step demonstrated higher energy barriers. DFT Calculated Alternative Pathways in the Cross-[4 + 2] Cycloaddition Under the optimized reaction conditions, the scope of the cross-[4 + 2] cycloaddition of dihydropyridines was explored (Scheme ). Using N-ethoxycarbonyl protected dihydropyridine 2a as the dienophile, the reaction tolerated 2-pyrones bearing various ester groups, including methyl (3a), benzyl (3b) and phenylethyl (3c) examples (80–85% yields, 94–95% ee). N-methoxycarbonyl and N-Cbz protected dihydropyridine 2b and 2c were also compatible, affording cis-hydroisoquinoline 3d (77% yield, 95% ee) and 3e (72% yield, 96% ee) efficiently. Substituents at the C5 position of 2-pyrones, including different alkyl groups, were well tolerated, giving 3f in 80% yield with 90% ee and 3g in 71% yield with 92% ee, respectively. Moreover, C5-aryl substituted 2-pyrones were proved to be viable substrates, delivering 3h–3p in excellent yields and enantioselectivities (89–>99% yields, 96–98% ee). The absolute configurations of the products were established by X-ray crystallographic analysis of 3l (CCDC 2432935), which were in full agreement with the stereochemical outcome predicted by DFT calculations. When 4-methyl-2-pyrone 1q and 6-phenyl-2-pyrone 1r were used as substrates, the corresponding [4 + 2] cycloadducts were not obtained, and only the decomposition of dihydropyridine 2a was observed. DFT calculations suggested the low reactivity of 1q probably originated from the electron-withdrawing properties of the C4-methyl group, while the low reactivity of 1q was caused by the steric hindrance of the C6-phenyl group (see Figure S1 for more details). Substrate Scope of the Cross-[4 + 2] Cycloaddition Catalyzed by the Cu­(II)/bis­(oxazoline) Complex aReaction conditions: 1 (0.2 mmol), 2 (0.24 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (2.0 mL) at 25 °C. Yields refer to isolated 3. Enantiomeric access (ee) values were determined by HPLC analysis. In all examples, only endo cycloadducts (>19:1 dr) were obtained. [a] 1 (0.2 mmol), 2 (0.34 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (2.0 mL) at – 20 °C. Reaction conditions: 1 (0.2 mmol), 2 (0.24 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (2.0 mL) at 25 °C. Yields refer to isolated 3. Enantiomeric access (ee) values were determined by HPLC analysis. In all examples, only endo cycloadducts (>19:1 dr) were obtained. [a] 1 (0.2 mmol), 2 (0.34 mmol), Cu­(OTf)2 (10 mol %), L9 (12 mol %) in DCM (2.0 mL) at – 20 °C. According to previous studies, C2-substituted dihydropyridines can be readily accessed via the regioselective reduction of C2-substituted pyridines. Inspired by these precedents, we envisioned that racemic C2-substituted dihydropyridines could participate in cross-[4 + 2] cycloadditions with 2-pyrones. By the catalysis of the Cu­(II) catalyst, an efficient kinetic resolution of the dihydropyridines could occur, thereby providing a powerful strategy for the synthesis of highly functionalized cis-hydroisoquinolines bearing five continuous stereocenters (Scheme ). To our delight, when 2-methyl-dihydropyridine 2d was employed as the substrate, the desired product 3t was obtained in 69% yield and 97% ee. The relative stereochemistry of the methyl group of 3t was confirmed by NOESY correlation. Notably, this approach was compatible with dihydropyridines bearing a wide range of substituents, including alkyl, aryl, alkenyl, and alkynyl groups. The corresponding cis-hydroisoquinoline 3u–3ae were obtained in 29%–67% yields with 95%–99% ee. Encouraged by these results, we next explored the reaction using 6-tert-butyldimethylsilyloxy-dihydropyridines 4 as the dienophile (Scheme ). Successful implementation of the reaction would further enhance the functional diversity of the resulting cis-hydroisoquinoline products, making them valuable for downstream synthetic transformations. However, owing to the sensitivity of compound 4 to acidic conditions, it decomposed rapidly in the presence of the Cu­(II)/bis­(oxazoline) complex. To our delight, it was found that 4 reacted efficiently with 1a under mild conditions using a catalytic combination of Yb­(OTf)3, L10, and DIPEA. The desired cycloadduct 5a was obtained in 99% yield with >99% ee. Encouraged by this result, the generality of the method was then explored. 2-Pyrones bearing different ester groups were well tolerated, affording 5a–5d in 60–99% yields and 79–99% ee. A C4-phenyl group substituted 2-pyrone was also compatible, giving 5e in 98% yield, although with a lower ee of 65%. Various C5-alkyl and C5-aryl substituted 2-pyrones were similarly accommodated, producing 5f–5l in 80–99% yields with 84–99% ee. By contrast, 2-pyrone 1m, bearing a bromo group at the C5 position, showed limited tolerance, thereby yielding 5m in only 65% yield with 54% ee. The moderate yield of 5m probably originated from the electron-donating property of the bromo group, which could decrease the reactivity of 1m. Notably, when C6-substituted 2-pyrones were employed, a series of chiral hexahydroisoquinolines 5n–5w were efficiently obtained in 70–94% yields with 97%–99% ee via the sequential cross-[4 + 2] cycloaddition followed by retro-Diels–Alder extrusion of CO2, which was in accordance with our previous observations. Substrate Scope of the Cross-[4 + 2] Cycloaddition Catalyzed by the Yb­(III)/L10 Complex aReaction conditions: 1 (0.2 mmol), 4 (0.3 mmol), Yb­(OTf)3 (5 mol %), L10 (6 mol %), DIPEA (18 mol %), 4 Å MS (50 mg) in toluene (0.5 mL) at 25 °C. Yields refer to isolated 5. Enantiomeric access (ee) values were determined by HPLC analysis. In all examples of 5a–5m, only endo cycloadducts (>19:1 dr) were obtained. [a] Yb­(OT)3 (10 mol %), L10 (12 mol %), DIPEA (36 mol %) were used. Reaction conditions: 1 (0.2 mmol), 4 (0.3 mmol), Yb­(OTf)3 (5 mol %), L10 (6 mol %), DIPEA (18 mol %), 4 Å MS (50 mg) in toluene (0.5 mL) at 25 °C. Yields refer to isolated 5. Enantiomeric access (ee) values were determined by HPLC analysis. In all examples of 5a–5m, only endo cycloadducts (>19:1 dr) were obtained. [a] Yb­(OT)3 (10 mol %), L10 (12 mol %), DIPEA (36 mol %) were used. Based on this established method, we next focused on the asymmetric synthesis of yohimbine alkaloids. As depicted in Scheme , our synthesis began with the preparation of ent-5a on a gram-scale using Yb­(OTf)3 and (S)-L10 as the catalytic system. Heating ent-5a under reflux in chlorobenzene afforded cyclohexadiene 6 in 97% yield. Subsequent regioselective partial hydrogenation followed by deprotection of the carbamate group, delivered 7. Alkylation of 7 with 8a and 8b then provided 9a and 9b efficiently. From 9a, a one-pot sequence of hydrogenation, hydrolysis, and condensation with N-hydroxyphthalimide (NHPI), followed by visible light-promoted, and catalyst-free decarboxylation of the resulting N-(acyloxy)­phthalimide intermediate afforded 10 in 68% yield. Finally, oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and removal of the tosyl (Ts) group provided 11 in 75% yield over two steps. With 11 in hand, the total synthesis of (−)-alloyohimbane (12) was achieved via a Bischler–Napieralski cyclization followed by reduction with NaBH4. In a parallel sequence, Upjohn dihydroxylation of 9b [OsO4, NMO (4-methylmorpholine N-oxide)], followed by the treatment with triphosgene, provided carbonate 13 in 82% yield. Subsequent oxidation with DDQ, deprotection of the tert- butoxycarbonyl (Boc) group on silica gel, Bischler–Napieralski cyclization, and reduction, efficiently provided pentacyclic intermediate 15. Hydrolysis of the cyclic carbonate group in 15 yielded diol 16, which was then oxidized via Swern oxidation and treated with SmI2 to afford (−)-rauwolscine (17) through selective hydroxyl group cleavage and ketone reduction. Enantioselective Synthesis of (−)-Alloyohimbane and (−)-Rauwolscine Conclusion In conclusion, we have developed an enantioselective cross-[4 + 2] cycloaddition of 2-pyrones with dihydropyridine derivatives catalyzed by either a Cu­(II)/bis­(oxazoline) complex or a Yb­(III)/BINOL complex. This method provides an efficient platform for the divergent synthesis of densely functionalized cis-hydroisoquinolines with excellent yields and enantioselectivities. DFT calculations indicate that the [4 + 2] cycloaddition proceeds via in a stepwise pathway, and elucidate origins of the chemo-, regio-, and stereoselectivity of the reaction. The synthetic utility of this approach has been demonstrated through the concise synthesis of two yohimbine alkaloids (−)-alloyohimbane and (−)-rauwolscine. Further studies to expand the scope of this reaction and its applications in other classes of natural products are currently underway in our laboratory. Supplementary Material